Michelle Lubetzky Selected Research

Michelle Lubetzky Research Topics

3	Viremia 01/2022 - 02/2014
3	Infections 01/2022 - 03/2013
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 06/2015
2	Diarrhea 01/2021 - 12/2019
2	Hypertension (High Blood Pressure) 01/2019 - 09/2015
2	Ischemia 07/2017 - 09/2015
2	Delayed Graft Function 07/2017 - 01/2016
2	Proteinuria 01/2017 - 01/2010
1	Fibrosis (Cirrhosis) 01/2022
1	Neoplasms (Cancer) 01/2022
1	COVID-19 01/2021
1	Bacteriuria 11/2020
1	Virus Diseases (Viral Diseases) 12/2019
1	Dysbiosis 12/2019
1	Obesity 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2018
1	Solitary Kidney 07/2017
1	Hepatitis C 01/2017
1	Heart Failure 09/2015
1	Hypertensive Crisis 09/2015
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 09/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2015
1	Urinary Tract Infections (Urinary Tract Infection) 06/2015
1	Urinary Retention 06/2015

2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2022 - 02/2014
2	serum P-component (CIt)IBA 07/2017 - 07/2017
1	ChromiumIBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	GlucuronidaseIBA 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	Butyrates (Butyrate)IBA 12/2019
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	Antiviral Agents (Antivirals)IBA 01/2017
1	InterferonsIBA 01/2017
1	ElectrolytesIBA 01/2016
1	CreatinineIBA 09/2015
1	Interferon-gamma (Interferon, gamma)IBA 02/2014
1	Messenger RNA (mRNA)IBA 03/2013
1	Bortezomib (Velcade)FDA Link 01/2010